WELCOME TO The Biotechnology REPORT
The affordability hurdle for gene therapies
October 12, 2022
I'm For Real
Enter your details once to access all our information and resources
Exosome Diagnostics, Inc. is commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases.
whitePaper | December 13, 2022
The global demand for plasmid DNA has increased
dramatically in recent years, fueled by a surge in the
clinical development of next-generation cell and gene
therapy products and more recently by the success of
whitePaper | August 19, 2022
The quality of procedures and products used for preparing, transporting and storing cells at cryogenic temperatures have a direct impact on post-thaw viability and functionality, as well as the consistency and reliability of biological agents from a Quality perspective.
whitePaper | December 22, 2022
Single-pass tangential flow filtration (SPTFF) technology from Pall Corporation is revolutionizing current and future
bioprocessing platforms with its implementations in biotech, vaccine and plasma industries. Its features are
protected by a portfolio of patents[1-6].
whitePaper | January 16, 2022
All gene therapies insert engineered DNA/RNA into living cells to make or modify new proteins
whitePaper | December 5, 2022
The adoption of LC-MS-based multi-attribute method (MAM) analysis for routine monitoring of biotherapeutic variation has progressed greatly over the last five years.
whitePaper | January 24, 2022
Since early 2020, coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome.
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE